Treatment of advanced bronchogenic carcinoma with adriamycin, 5-fluorouracil and methotrexate.
The combination of adriamycin, 5-fluorouracil and methotrexate with folinic acid reversal was used to treat patients with advanced bronchogenic carcinoma. Twenty-one of 30 patients showed an objective response. This combination appears to produce useful remissions in patients with non-squamous lung cancer.
D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D012075:Remission, Spontaneous; D013997:Time Factors
D004317:Doxorubicin; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate